Rocket Lab USA Inc (RKLB) Stock Price Today
TrussPoint adopts ServiceTitan to boost growth across its residential roofing brands.
TrussPoint, a residential exterior services investment platform, has chosen ServiceTitan's software to support growth across its portfolio of roofing brands. ServiceTitan will provide operational tools to help TrussPoint maintain local brand cultures...
GrowGeneration joins U.S. Cannabis Roundtable to influence federal cannabis policy and support industry growth.
GrowGeneration Corp., a leading supplier for controlled environment agriculture, has joined the U.S. Cannabis Roundtable (USCR) to help shape federal cannabis regulations. Represented by CEO Darren Lampert, GrowGeneration aims to leverage its agricul...
Zapata Quantum CEO to present on NVIDIA collaboration and quantum cancer research at July 9 investor conference
Zapata Quantum announced that CEO Sumit Kapur will present live at the Global Technology Virtual Investor Conference on July 9, highlighting the company's collaboration with NVIDIA to accelerate quantum algorithm development and its quantum-enabled c...
Transthyretin Amyloidosis Treatment Market to hit $35.1B by 2035, growing at 14.64% CAGR driven by new RNAi therapies and diagnostics.
The global Transthyretin Amyloidosis Treatment Market, valued at $8.95 billion in 2025, is projected to reach $35.10 billion by 2035 with a CAGR of 14.64%. Growth is fueled by advances in gene-silencing RNAi therapies like patisiran and vutrisiran, i...
AI legal drafting tools market to grow from $0.9B in 2025 to $3.42B by 2030, driven by automation and AI advances.
The AI legal drafting tools market is projected to expand rapidly from $0.9 billion in 2025 to $3.42 billion by 2030, with a CAGR of about 30.7%. Growth is fueled by increasing demand for automation in legal processes, adoption of AI-powered contract...
EMA speeds up review of Revolution Medicines' daraxonrasib for pancreatic cancer after strong Phase 3 trial results
The European Medicines Agency (EMA) has begun a phased review of daraxonrasib, an investigational drug by Revolution Medicines for pancreatic cancer, following unprecedented Phase 3 trial results showing improved survival and quality of life. Daraxon...
REIT ETF gains 17% YTD despite no Fed rate cuts, showing resilience and income potential.
The ALPS Active REIT ETF has risen over 17% year-to-date, performing well even without Federal Reserve interest rate cuts that typically benefit real estate. This ETF combines active management with real estate investment trusts (REITs), offering inv...
Income ETF GPIQ surpasses $5B AUM with strong inflows ahead of 3-year milestone in October
Goldman Sachs' income ETF GPIQ recently crossed $5 billion in assets under management, fueled by over $2 billion in inflows this year. Launched in October 2023, GPIQ is set to reach its three-year operational milestone this October, which could attra...
Gold ETF GDE may rally as markets rethink Fed rate hike outlook after soft jobs data.
Gold prices gained last week, raising hopes for a stronger second half of 2026. The WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE), which invests in gold futures and large-cap stocks, could benefit if gold rallies. Experts suggest markets ...
Active international ETF TOUS hits 3-year mark with strong returns and buy signals amid diversification demand.
The T. Rowe Price International ETF (TOUS) recently celebrated its three-year anniversary, marking a milestone that often attracts more investor attention. This actively managed international equity fund has returned 19% over the past year and shows ...